Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Defined term · Outcomes and endpoints

Surrogate outcome

A measurement substituted for a clinical outcome on the assumption that a change in one predicts a change in the other. Validation of that assumption requires trial-level evidence across…

Document identifier
CEI-GT-090
Series
Defined term
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Surrogate outcome

§1.1Also known as

Surrogate endpoint

§1.2Category

Outcomes and endpoints — Terms describing what a study measures and what the measurement supports.

§1.3Related terms

  • Indirectness — A mismatch between the population, intervention, comparator or outcome of the contributing studies and those of the question being answered. Also applied where an…
  • Clinical outcome — An outcome a person would notice or care about directly: death, an event, a symptom, a function. Distinguished throughout the document set from a surrogate.
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.